Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings Inc. is a clinical- and commercial-stage biotechnology company specializing in regenerative medicine and immunotherapy. The company focuses on stem cell–based therapies addressing unmet needs across orthopedics, endocrinology, immunology, urology, and gynecology. Its pipeline includes proprietary platforms such as Olastrocel, a leading allogeneic cell therapy candidate for chronic lower back pain and metabolic indications, as well as ImmCelz, a personalized immune cell technology designed to modulate immune responses. Creative Medical Technology Holdings Inc. also develops and commercializes procedures and products for sexual health and infertility, including applications for erectile dysfunction, female sexual dysfunction, and premature ovarian failure. Headquartered in Phoenix, Arizona and founded in 1998, the company operates through multiple cell-based platforms using adult and perinatal stem cell technologies, aiming to deliver clinically validated regenerative treatments to patients via physician networks and specialized clinical programs.